Assessment of liver fibrosis by transient elastography in rheumatoid arthritis patients treated with methotrexate

Joint Bone Spine

Volumn 77, Issue 6, 2010, Pages 588-592

  Park, Sung Hoon ^a   Choe, Jung Yoon ^a   Kim, Seong Kyu ^a  

^a Catholic University of Daegu   (South Korea)

Author keywords

Liver fibrosis; Methotrexate; Rheumatoid arthritis; Transient elastography

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HAPTOGLOBIN; METHOTREXATE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOCHEMISTRY; CONTROLLED STUDY; ELASTOGRAPHY; FEMALE; HUMAN; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRESSURE; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SEROLOGY;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BLOOD CHEMICAL ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; METHOTREXATE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 78649905628     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2010.02.024     Document Type: Article

References (30)

1. Combe B., Landewe R., Lukas C., et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007, 66:34-45.
2. Saag K.G., Teng G.G., Patkar N.M., et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008, 59:762-784.
3. Afdhal N.H., Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004, 99:1160-1174.
4. Bravo A.A., Sheth S.G., Chopra S. Liver biopsy. N Engl J Med 2001, 344:495-500.
5. Castera L., Forns X., Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008, 48:835-847.
6. Farber S., Diamond L.K. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. N Engl J Med 1948, 238:787-793.
7. Weinblatt M.E., Coblyn J.S., Fox D.A., et al. Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med 1985, 312:818-822.
8. Tian H., Cronstein B.N. Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis. Bull NYU Hosp Jt Dis 2007, 65:168-173.
9. Swierkot J., Szechinski J. Methotrexate in rheumatoid arthritis. Pharmacol Rep 2006, 58:473-492.
10. Salliot C., van der Heijde D. Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis 2009, 68:1100-1104.
11. Katchamart W., Trudeau J., Phumethum V., et al. Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis. Ann Rheum Dis 2009, 68:1105-1112.
12. Kremer J.M., Lee J.K. The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. Arthritis Rheum 1986, 29:822-831.
13. Hughes L.B., Beasley T.M., Patel H., et al. Racial or ethnic differences in allele frequencies of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis. Ann Rheum Dis 2006, 65:1213-1218.
14. Kim S.K., Jun J.B., El-Sohemy A., et al. Cost-effectiveness analysis of MTHFR polymorphism screening by polymerase chain reaction in Korean patients with rheumatoid arthritis receiving methotrexate. J Rheumatol 2006, 33:1266-1274.
15. Ranganathan P., Culverhouse R., Marsh S., et al. Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis. J Rheumatol 2008, 35:572-579.
16. Dervieux T. Pharmacogenomics of methotrexate in rheumatoid arthritis: does race make a difference?. J Rheumatol 2008, 35:550-552.
17. Ahern M.J., Smith M.D., Roberts-Thomson P.J. Methotrexate hepatotoxicity: what is the evidence?. Inflamm Res 1998, 47:148-151.
18. Kremer J.M., Lee R.G., Tolman K.G. Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples. Arthritis Rheum 1989, 32:121-127.
19. EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. Consensus statement. J Hepatol 1999;31 (Suppl. 1):3-8.
20. Bedossa P., Dargere D., Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003, 38:1449-1457.
21. Rousselet M.C., Michalak S., Dupre F., et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005, 41:257-264.
22. Sandrin L., Fourquet B., Hasquenoph J.M., et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003, 29:1705-1713.
23. Kettaneh A., Marcellin P., Douvin C., et al. Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J Hepatol 2007, 46:628-634.
24. Fraquelli M., Rigamonti C., Casazza G., et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007, 56:968-973.
25. Castera L., Vergniol J., Foucher J., et al. Prospective comparison of transient elastography, Fibrotest. APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005, 128:343-350.
26. Foucher J., Castera L., Bernard P.H., et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 2006, 18:411-412.
27. Coco B., Oliveri F., Maina A.M., et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 2007, 14:360-369.
28. Laharie D., Zerbib F., Adhoute X., et al. Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn's disease patients treated with methotrexate. Aliment Pharmacol Ther 2006, 23:1621-1628.
29. Kang J.K., Cheong J.Y., Cho S.W., et al. [Liver stiffness measurement for the diagnosis of hepatic fibrosis in patients with chronic viral hepatitis]. Korean J Hepatol 2007, 13:521-529.
30. Farrell G.C., Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006, 43:S99-S112.